Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

In the years leading up to its bankruptcy filing, the company also struggled with the growth of free or low-cost ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in ...

The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots ...

A conference poster presented at the European Congress on Obesity (ECO) looks at weight loss drugs (GLP-1s) and reduced alcohol intake. Prof Kevin McConway, Emeritus Professor of Applied Statistics, ...

Founded in 1963 by Jean Nidetch, WeightWatchers began as a weekly weight-loss support group with just 400 attendees. It quickly grew into a global phenomenon, attracting millions of members worldwide ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Obesity drugmaker Novo Nordisk downgraded its 2025 sales forecast on ...